ACVA · As filed with the SEC
ACV Auctions balance sheet, by fiscal year
The statement as ACV Auctions presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED BALANCE SHEETS · USD thousands, shares in thousands
| USD thousands, shares in thousands | FY2025 Dec 31, 2025 | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | FY2021 Dec 31, 2021 | FY2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Current Assets: | ||||||
| Cash and cash equivalents | 271,497 | 224,065 | 182,571 | 280,752 | 565,994 | 233,725 |
| Marketable Securities | — | — | 228,761,000 | 215,926,000 | 13,765,000 | — |
| Marketable securities | 0 | 46,036 | — | — | — | — |
| Trade receivables (net of allowance of $3,829 and $6,372) | 197,225 | 168,770 | 164,009 | 168,732 | 222,753 | 104,138 |
| Finance receivables (net of allowance of $29,026 and $4,191) | 180,486 | 139,045 | 119,034 | 78,047 | 44,278 | 8,501 |
| Other current assets | 24,295 | 15,281 | 12,524 | 11,317 | 10,623 | 8,041 |
| Total current assets | 673,503 | 593,197 | 706,899 | 754,774 | 857,413 | 354,405 |
| Property and equipment (net of accumulated depreciation of $6,589 and $5,227) | 12,852 | 7,625 | 4,918 | 5,710 | 4,916 | 4,912 |
| Goodwill | 183,725 | 180,478 | 103,379 | 91,755 | 78,839 | 21,820 |
| Acquired intangible assets (net of amortization of $40,202 and $28,972) | 81,024 | 90,816 | 34,192 | 19,291 | 18,130 | 11,491 |
| Internal-use software costs (net of amortization of $6,930 and $3,857) | — | — | 55,771,000 | 36,992,000 | 17,844,000 | 7,775,000 |
| Operating lease right-of-use assets | — | — | — | — | 3,264,000 | 2,000,000 |
| Internal-use software costs (net of amortization of $67,874 and $38,499) | 81,964 | 68,571 | — | — | — | — |
| Other assets | 52,543 | 43,462 | 17,765 | 6,400 | 2,554 | 2,147 |
| Total assets | 1,085,611 | 984,149 | 922,924 | 914,922 | 982,960 | 404,550 |
| Liabilities and Stockholders' Equity | ||||||
| Current Liabilities: | ||||||
| Accounts payable | 390,830 | 345,605 | 305,845 | 323,661 | 395,972 | 151,967 |
| Accrued payroll | 9,308 | 16,725 | 12,245 | 10,052 | 11,961 | 8,109 |
| Accrued other liabilities | 20,711 | 18,836 | 15,851 | 14,504 | 9,806 | 4,375 |
| Deferred revenue | — | — | — | — | 4,317,000 | 1,504,000 |
| Operating lease liabilities | — | — | — | — | 1,306,000 | 746,000 |
| Total current liabilities | 420,849 | 381,166 | 333,941 | 348,217 | 423,362 | 166,701 |
| Long-term operating lease liabilities | — | — | — | — | 2,049 | 1,323 |
| Long-term debt | 190,000 | 123,000 | 115,000 | 75,500 | 500 | 4,832 |
| Other long-term liabilities | 45,079 | 39,979 | 17,455 | 5,481 | 952 | 5,054 |
| Total liabilities | 655,928 | 544,145 | 466,396 | 429,198 | 426,863 | 177,910 |
| Convertible preferred stock; $0.001 par value; 0 and 230,538,501 shares authorized; 0 and 115,269,221 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively | — | — | — | — | 0 | 366,332 |
| Stockholders' Equity: | ||||||
| Preferred stock; $0.001 par value; 20,000 shares authorized; 0 and 0 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 0 | 0 | 0 | 0 | 0 | 0 |
| Common stock | — | — | — | — | — | 22 |
| Common Class A | — | 168 | 139 | 121 | 106 | — |
| Common Stock | 173 | — | — | — | — | — |
| Common Class B | 0 | 0 | 23 | 37 | 50 | — |
| Additional paid-in capital | 996,628 | 944,891 | 880,510 | 836,695 | 801,142 | 27,322 |
| Accumulated deficit | (568,456) | (502,315) | (422,615) | (347,354) | (245,161) | (166,979) |
| Accumulated other comprehensive income (loss) | 1,338 | (2,740) | (1,529) | (3,775) | (40) | (57) |
| Total stockholders' equity | 429,683 | 440,004 | 456,528 | 485,724 | 556,097 | (139,692) |
| Total liabilities and stockholders' equity | 1,085,611 | 984,149 | 922,924 | 914,922 | 982,960 | 404,550 |
| Common Stock | 2,000,000 | — | — | — | — | — |
| Common Class B | 0 | — | — | — | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.